Lexington, KY – On June 10th OmniLife was announced as the recipient of the 2021 BioLOGIC Innovation Award of $50k.
Designed to promote innovation, entrepreneurship and transformative impact in the life sciences, the bioLOGIC Innovation Awards (BIAs) are open to early stage companies working to advance human health with biotechnology in Kentucky, Ohio and Indiana.
OmniLife plans to leverage their network comprised of industry experts and awarded funds to quickly scale their organ donation and transplant tools, into other segments in the allotransplant industry, specifically helping connect researchers with non-transplantable organs and tissues.
“I am very excited to work with the bioLOGIC team to accelerate our penetration and success into the research segment. Our goal is to ensure that every organ finds a home. We will do this by providing better organ offer review and screening tools for researchers and make it easier for organ procurement organizations (OPO) to easily offer organs for purposes of research,” said OmniLife CEO Dalton Shaull.
About bioLOGIC: BioLOGIC provides mentorship, learning opportunities and financial support to startup companies working to develop new and improved technology platforms, products or resources that serve the region and beyond.
About OmniLife: OmniLife is Fixing a Broken System – The system for donation of organs and tissues for purposes of transplantation and research is fragmented, inefficient, and fails to address unsustainable supply and costs. OmniLife is an integrated solution that works for everyone – whether you are a provider, supplier, processor, or researcher OmniLife is the only end-to-end communication system that is built specifically to create a more connected and collaborative allotransplant ecosystem. The OmniLife platform integrates with every key stakeholder in the supply and demand chain in order to increase efficiency, reduce cost, and place more organs and tissues for transplantation and to power life-saving research.